73,95 €
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
37 °P sammeln
73,95 €
73,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
37 °P sammeln
Als Download kaufen
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
37 °P sammeln
Jetzt verschenken
73,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
37 °P sammeln
  • Format: PDF

This book offers ophthalmologists and medical practitioners a concise, data-driven review of the information that is most relevant in guiding the diagnosis and management of thyroid eye disease (TED). Particular attention is devoted to research and clinical trials that have advanced the field in recent years.
Progress in our understanding of the pathogenesis of TED is described, and the heterogeneous natural history of TED is discussed to facilitate preemptive interventions. Advances in diagnostic evaluation, including autoantibody assessment, are reviewed with regard to their clinical
…mehr

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 13.79MB
Produktbeschreibung
This book offers ophthalmologists and medical practitioners a concise, data-driven review of the information that is most relevant in guiding the diagnosis and management of thyroid eye disease (TED). Particular attention is devoted to research and clinical trials that have advanced the field in recent years.

Progress in our understanding of the pathogenesis of TED is described, and the heterogeneous natural history of TED is discussed to facilitate preemptive interventions. Advances in diagnostic evaluation, including autoantibody assessment, are reviewed with regard to their clinical utility. The diagnostic features of euthyroid TED are also carefully covered since these patients often represent a diagnostic dilemma.

All relevant aspects of treatment are addressed including the role of radioactive iodine, long-term medical therapy, and surgical thyroidectomy. The impact of these treatment modalities on eye disease are discussed. Management of active TED is reviewed according to the severity of disease and in the light of recent findings and the introduction of novel agents. The discussion encompasses the role of steroids and other agents, the use of novel biologics, the medical and surgical treatment of optic neuropathy, and minimally invasive, customized reconstructive surgery. Numerous supporting images are included, and helpful checklists will aid the practitioner in treatment decision making.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Raymond S. Douglas, MD, PhD, studied at the University of Pennsylvania and subsequently completed his residency in ophthalmology at the Scheie Eye Institute, University of Pennsylvania and his fellowship in orbital facial plastic and reconstructive surgery at the Jules Stein Eye Institute, University of California, Los Angeles. He is currently Associate Professor of Ophthalmology and Visual Sciences and a specialist in eye plastic, orbital, and facial cosmetic Surgery at the University of Michigan, Kellogg Eye Institute. Dr. Douglas' particular interests include orbital surgery, especially minimally invasive surgery, and decompressions for thyroid-associated eye disease; cosmetic facial surgery; and post-cancer reconstruction, including Mohs surgery. Allison N. McCoy, MD, PhD, undertook her medical training at Duke University, Durham, North Carolina and also gained a doctorate in Neurobiology from the same university. Between 2008 and 2011 she served an Ophthalmology Residency at the Wilmer Eye Institute, Baltimore, and she is currently a Fellow in Eye Plastic, Orbital, and Facial Cosmetic Surgery. Dr. McCoy has been involved in a number of research projects and has been the recipient of the Neil Miller Research Grant Award, the Michael Boland Research Grant Award, the Mitchell Prize for Resident Research, and a Heed Fellowship. She is the author of 15 peer-reviewed publications. Shivani Gupta, MD, MPH is an Eye Plastic, Orbital and Facial Cosmetic Surgery Lecturer in the Department of Ophthalmology and Visual Sciences at the University of Michigan. Her special interests include orbital surgery, cosmetic facial surgery including fillers and Botox injections, eyelid and lacrimal disorders, post-cancer reconstruction including Mohs' surgery.
Rezensionen
From the book reviews:

"The purpose is to help summarize and interpret the most recent studies and data related to thyroid eye disease. This book is useful for ophthalmologists, endocrinologists, general physicians, and residents. ... This is an outstanding book that helps summarize important advances in the management of patients with thyroid eye disease. It is well written and extremely useful for those managing these difficult patients." (Christopher B. Chambers, Doody's Book Reviews, March, 2015)